Cannabinoid Discrimination

Cannabinoid Discrimination is a drug discrimination paradigm in behavioral pharmacology wherein subjects are trained to recognize the interoceptive effects of cannabinoid agonists, thereby enabling the study of cannabinoid receptor activation and its role in perceptual and behavioral specificity.

113

Publications

4.7K

Citations

291

Authors

96

Institutions

Publications per year

2017–2026

16

Authors

291

  1. JL
    Jenny L. Wiley

    RTI International, United States

    16 publications · 785 citations

    15

    h-index

  2. TU
    Torbjörn U.C. Järbe

    Uppsala University, Sweden

    16 publications · 403 citations

    13

    h-index

  3. AM
    Alexandros Makriyannis

    Northeastern University, United States

    8 publications · 224 citations

    8

    h-index

  4. BR
    Billy R. Martin

    Virginia Commonwealth University Medical Center, United States

    8 publications · 423 citations

    8

    h-index

  5. LR
    Lance Richard McMahon

    The University of Texas at San Antonio Health Science Center, United States

    8 publications · 317 citations

    8

    h-index

1–5 of 291

Venues

  1. Psychopharmacology

    26 publications · 1.1K citations

    22

    h-index

  2. Behavioural Pharmacology

    12 publications · 397 citations

    12

    h-index

  3. 12

    h-index

  4. Pharmacology Biochemistry and Behavior

    8 publications · 253 citations

    8

    h-index

  5. Drug and Alcohol Dependence

    7 publications · 330 citations

    7

    h-index

1–5